Matinas BioPharma Holdings, Inc.

MTNB

Exchange: NYSE
Industry: Pharmaceutical Preparations
SEC CIK: 0001582554

SEC filings (opens in a new tab)

No open-market purchases or sales by Matinas BioPharma Holdings, Inc. insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $199.2K in total; no superinvestor holds it.

Superinvestors holding MTNB, Q2 2026

See all superinvestors

No superinvestor reported holding MTNB in Q2 2026.